Europe Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Liver Organoids, Liver-on-a-chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

TIPRE00026112 | Pages: 119 | Biotechnology | Nov 2021 | Type: Regional | Status: Published
The Europe human liver models market is expected to grow from US$ 84,347.25 thousand in 2021 to US$ 1,87,244.81 thousand by 2028; it is estimated to grow at a CAGR of 12.1% from 2021 to 2028.

The UK, Germany, France, Italy, and Spain are major economies in Europe. Escalating focus on developing alternatives for animal testing models is expected to surge the market growth. There has been an increase in the number of animals used in research with the rising research and development in medical industry. These animals are required in huge numbers in preclinical testing. Pain, distress, and death of animals during scientific experiments have been a topic of discussion for a long time. Several cases show that animal models cannot always predict the body’s response to drugs, especially during drug toxicology studies. This is because the metabolism of drugs and toxins in humans differs significantly from animals, making it almost impossible to study drug metabolism in experimental models such as laboratory rodent species. The field of alternative research has accelerated over the past 30 years. In addition, several regulations have been introduced in recent years that restrict the use of animals in research activities around the region. Methods such as in vitro testing, cell cultures, computer simulations, and new imaging/analysis techniques have been proposed as an alternative means of drug and chemical testing to avoid excessive use of animals. Bioinformatic tools, in vitro cell cultures, enzymatic screens, and model organisms are necessary to integrate various computer models. The use of modern analytical techniques, data collection, and statistical methods to analyze the results of alternative protocols can provide reliable results. Further, these methods are less time consuming and cost-efficient, and require a limited workforce. With the advent of three-dimensional (3D) cell culture to make organoids, more relevant human organoid models are being explored to provide safe and effective drug testing, thus minimizing the need for animal testing. It is necessary to develop alternative test models that can provide an environment as close as possible to the human body. Various institutes are involved in developing alternative methods for drug development and biomedical research. Since liver models can serve as an alternative to animal models, the current focus on reducing animal use in research is expected to support the Europe human liver models market growth.
In the case of COVID-19, Europe is highly affected especially France and Russia. The current COVID-19 outbreak has not caught EU-funded research off guard. The MSCA of the European Commission supports outstanding researchers in finding solutions to challenges posed by the novel coronavirus disease COVID-19 and other infectious diseases. Also, to facilitate the launch of clinical trials relating to COVID-19, authorities have allowed expedited authorization procedures for the initial assessment of authorization requests. However, remerging waves of COVID-19 have mixed impacts on the market due to the closing of clinical trials sites. As per Phesi's analysis from September 2020, global clinical trial sites suspensions peaked in June, and after an initial drop, had risen again and had a significant impact on phase 2 and 3 trials. With increased global economic uncertainty across sectors, 2021 is expected to be challenging for most clinical development organizations worldwide. Clinical research is vital to developing new treatments and improved understanding of disease, and COVID-19 presents many challenges. The Governments in the region are planning a safe and sustainable restart of non-COVID trials. As of September 2020, the NIHR Clinical Research Network data has shown that non-COVID studies are restarting, with 45% of studies open to recruitment. Additionally, organoids are being used by researchers around the EuroStemCell partnership. For example, an international group of scientists, including researchers from IMBA Institute of Molecular Biotechnology of the Austrian Academy of Sciences, slowed SARS-CoV-2 infection in organoids, demonstrating the potential blocking effect of a drug already in clinical trials. The researchers are undergoing various research to manage the COVID-19 outbreak. Thus, increased research activities will lead to vital opportunities for the market.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe human liver models market. The Europe human liver models market is expected to grow at a good CAGR during the forecast period.

Europe Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)

Europe Human Liver Models Market Segmentation
Europe Human Liver Models Market By Type
- Liver Organoids
- Liver-on-a-chip
- 2D Models
- 3D Bioprinting
- Others
Europe Human Liver Models Market By Application
- Drug Discovery
- Educational
- Others
Europe Human Liver Models Market By End User
- Pharmaceutical and Biotechnology Companies
- Research Institutes
- Others
Europe Human Liver Models Market, by Country
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Europe Human Liver Models Market -Companies Mentioned
- BioIVT
- CELLINK
- CN Bio Innovations
- Cyprio
- Emulate, Inc.
- InSphero
- Kerafast
- Kirkstall
- MIMETAS BV
- THERMO FISHER SCIENTIFIC INC.

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Human Liver Models Market By Type
1.3.2 Europe Human Liver Models Market By Application
1.3.3 Europe Human Liver Models Market By End User
1.3.4 Europe Human Liver Models Market By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Human Liver Models Market Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Human Liver Models Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Prevalence of Liver Diseases
5.1.2 Escalating Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
5.2.1 Overpriced Liver Models
5.3 Market Opportunities
5.3.1 Growing focus on Drug Discovery Activities
5.4 Future Trends
5.4.1 Increasing Technological Advancements in Organ Printing
5.1 Impact analysis
6. Human Liver Models Market Europe Analysis
6.1 Europe Human Liver Models Market Revenue Forecast and Analysis
7. Europe Human Liver Models Market Analysis By Type
7.1 Overview
7.2 Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
7.3 Liver Organoids
7.3.1 Overview
7.3.2 Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.4 Liver-on-a-chip
7.4.1 Overview
7.4.2 Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.5 2D Models
7.5.1 Overview
7.5.2 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.6 3D Bioprinting
7.6.1 Overview
7.6.2 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
7.7 Others
7.7.1 Overview
7.7.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8. Europe Human Liver Models Market Analysis By Application
8.1 Overview
8.2 Europe Human Liver Models Market Share, by Application, 2021 and 2028, (%)
8.3 Educational
8.3.1 Overview
8.3.2 Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
8.5 Other
8.5.1 Overview
8.5.2 Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9. Europe Human Liver Models Market Analysis By End User
9.1 Overview
9.2 Europe Human Liver Models Market Share, by End User, 2021 and 2028, (%)
9.3 Research Institutes
9.3.1 Overview
9.3.2 Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
9.5 Others
9.5.1 Overview
9.5.2 Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
10. Europe Human Liver Models Market Country Analysis
10.1 Europe: Human Liver Models Market
10.1.1 Overview
10.1.2 Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
10.1.2.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.1 Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.2 Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.3 Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.1.4 Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.1 France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.2 France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.3 France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.2.4 France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.1 UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.2 UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.3 UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.3.4 UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.1 Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.2 Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.3 Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.4.4 Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.1 Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.2 Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.3 Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.5.4 Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.1 Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.2 Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.3 Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
10.1.2.6.4 Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
11. Impact Of COVID-19 Pandemic on Europe Human Liver Models Market
11.1 Europe: Impact Assessment Of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Emulate, Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CN Bio Innovations
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MIMETAS BV
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 InSphero
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioIVT
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 CELLINK
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Kerafast
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Cyprio
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Kirkstall
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms


LIST OF TABLES
Table 1. Europe Human Liver Models Market, Revenue and Forecast, 20192028 (US$ Thousand)
Table 2. Germany: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 3. Germany: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 4. Germany: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 5. France: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 6. France: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 7. France: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 8. UK: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 9. UK: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 10. UK: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Spain: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Spain: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 13. Spain: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 14. Italy: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 15. Italy: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 16. Italy: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Rest of Europe: Human Liver Models Market, by Type Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Rest of Europe: Human Liver Models Market, by Application Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Rest of Europe: Human Liver Models Market, by End User Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Organic Developments Done by Companies
Table 21. Inorganic Developments Done by Companies
Table 22. Glossary of Terms


LIST OF FIGURES
Figure 1. Europe Human Liver Models Market Segmentation
Figure 2. Europe Human Liver Models Market Segmentation, By Country
Figure 3. Europe Human Liver Models Market Overview
Figure 4. Liver Organoids Held the Largest Share in 2020
Figure 5. The UK to Show Significant Growth During Forecast Period
Figure 6. Europe and PEST Analysis
Figure 7. Europe Human Liver Models Market Impact Analysis of Drivers and Restraints
Figure 8. Europe Human Liver Models Market Revenue Forecast and Analysis
Figure 9. Europe Human Liver Models Market Revenue Share, by Type (2021 and 2028)
Figure 10. Europe Liver Organoids: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 11. Europe Liver-on-a-chip: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 12. Europe 2D Models: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 13. Europe 3D Bioprinting: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 14. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 15. Europe Human Liver Models Market Share, by Application, 2021 and 2028 (%)
Figure 16. Europe Educational: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 17. Europe Drug Discovery: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 18. Europe Other: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 19. Europe Human Liver Models Market Share, by End User, 2021 and 2028 (%)
Figure 20. Europe Research Institutes: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 21. Europe Pharmaceutical and Biotechnology Companies: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 22. Europe Others: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousands)
Figure 23. Europe: Human Liver Models Market, by Key Country Revenue (2021) (USD Thousand)
Figure 24. Europe: Human Liver Models Market, by Country, 2021 & 2028 (%)
Figure 25. Germany: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 26. France: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 27. UK: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 28. Spain: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 29. Italy: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 30. Rest of Europe: Human Liver Models Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 31. Impact of COVID-19 Pandemic in European Country Markets

1. BioIVT
2. CELLINK
3. CN Bio Innovations
4. Cyprio
5. Emulate, Inc.
6. InSphero
7. Kerafast
8. Kirkstall
9. MIMETAS BV
10. THERMO FISHER SCIENTIFIC INC.

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe human liver models market. - Highlights key business priorities in order to assist companies to realign their business strategies - The key findings and recommendations highlight crucial progressive industry trends in the Europe human liver models market, thereby allowing players across the value chain to develop effective long-term strategies - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets - Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the human liver models market, as well as those hindering it - Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000